IPS细胞衍生类器官的全球市场:类型·用途·终端用户·不同地区的预测 (～2032年)

全球IPS细胞衍生类器官市场规模预计将从2023年的4.4亿美元成长到2024年的5.1亿美元，预测期内复合年增长率为17.8%，到2032年将达到18%。至9000 万美元。

IPS 细胞衍生的类器官市场代表了生物医学研究和药物开发的突破。这些由诱导多能干细胞 (iPS 细胞) 创建的微型 3D 组织模型为研究人类生理学、疾病机制和药物疗效提供了前所未有的机会。类器官有多种应用，包括疾病建模、药物发现、个人化医疗和再生治疗。在技​​术进步、个人化医疗需求不断增长以及药物发现和再生医学应用不断扩大的推动下，iPS 细胞衍生的类器官市场预计将显着增长。然而，克服技术、监管和道德挑战对于充分发挥这项创新技术的潜力至关重要。

区域洞察

北美 IPS 细胞衍生类器官市场拥有强大的研究基础设施、对生命科学的大量投资以及蓬勃发展的生物技术产业。该地区拥有干细胞研究前沿的一些顶尖大学和研究中心，该市场正在接受大量公共和私人投资，以推动 iPS 细胞衍生类器官的开发和应用。北美拥有完善的医疗体系，很容易引进先进的医疗技术。先进的研究设施和熟练的专业人员的存在也进一步促进了市场的成长。该地区的技术采用工作正在加速基于类器官的平台的开发和应用。支持性的监管框架也鼓励对类器官研究和发展的投资。

由于其对医疗保健的关注和推动市场发展的强大科学界，欧洲在 IPS 细胞衍生类器官市场中占有第二大占有率。德国 IPS 细胞衍生类器官供应商预计将占据最大的市场占有率，而法国 IPS 细胞衍生类器官供应商预计将成为该地区成长最快的。

由于生物医学研究投资的增加、医疗保健支出的增加以及慢性病患病率的上升推动了IPS 细胞衍生类器官的研究和开发，预计亚太地区IPS 细胞衍生类器官市场将在2023 年实现增长。

本报告提供全球IPS细胞衍生类器官的市场调查，市场定义和概要，市场成长的各种影响因素分析，市场规模的转变·预测，各种区分·地区/各主要国家的明细，竞争环境，主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

• 促进因素
  • 越来越多采用个人化药物
  • 慢性病的蔓延
  • 干细胞研究的进展
  • 促进因素影响分析
• 阻碍因素
  • 开发维护类器官的成本高昂
  • 监管障碍和标准化
  • 抑制因子影响分析
• 机会
  • 开发更复杂、功能更丰富的类器官
  • 扩大在药物发现和毒理学的应用
• COVID-19影响分析

第5章 市场要素分析

• 波特的五力分析
• 供应链分析

第6章 全球IPS细胞衍生类器官市场:各类型

• 概要
• 脑
• 心臟
• 肺
• 肝臟
• 肾臟
• 其他

第7章 全球IPS细胞衍生类器官市场:各用途

• 概要
• 医药品的发现·开发
• 疾病建模
• 再生医疗

第8章 全球IPS细胞衍生类器官市场:各终端用户

• 概要
• 製药·生物科技企业
• 学术研究机关
• CRO

第9章 全球IPS细胞衍生类器官市场:各地区

• 概要
• 北美
• 欧洲
• 亚太地区
• 其他地区

第10章 竞争情形

• 主要成长策略
• 竞争仪表板

第11章 企业简介

• ACROBIOSYSTEMS
• MILTENYI BIOTEC
• THERMOFISHER SCIENTIFIC
• STEMCELL TECHNOLOGIES
• BIO-TECHNE
• MERCK KGAA
• MOLECULAR DEVICES, LLC
• CORNING INCORPORATED
• PROMEGA CORPORATION
• CREATIVE BIOARRAY

Global IPS Cell Derived Organoids Market Research Report Information by Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others), by Application (Drug Discovery and Development, Disease Modelling, and Regenerative Medicine), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organization), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Forecast till 2032

An Overview of the Market

IPS Cell Derived Organoids Market size was valued at USD 0.44 billion in 2023. The IPS Cell Derived Organoids Market industry is projected to grow from USD 0.51 billion in 2024 to USD 1.89 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.8% during the forecast period (2024 - 2032).

IPS cell-derived organoids market represent a revolutionary advancement in biomedical research and drug development. These miniature, three-dimensional tissue models, generated from induced pluripotent stem cells (iPSCs), offer unprecedented opportunities for studying human physiology, disease mechanisms, and drug efficacy. Organoids are used in various applications, including disease modelling, drug discovery, personalized medicine, and regenerative therapies. The iPS cell-derived organoids market is poised for substantial growth, driven by technological advancements, increasing demand for personalized medicine, and expanding applications in drug discovery and regenerative medicine. However, overcoming technical, regulatory, and ethical challenges will be crucial for realizing the full potential of this transformative technology.

Market segmentation insights

The IPS Cell Derived Organoids Market segmentation, based on type, includes Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others.

The IPS Cell Derived Organoids Market segmentation, based on application, includes drug discovery and development, disease modelling, and regenerative medicine.

Regional Insights

The IPS Cell Derived Organoids market in America boasts a robust research infrastructure, substantial investments in life sciences, and a thriving biotechnology industry. North America is home to several top-tier universities and research centers that are at the forefront of stem cell research. This region has seen substantial investments from both public and private sectors aimed at advancing the development and application of iPS cell-derived organoids. The well-established healthcare systems in North America facilitate the adoption of advanced medical technologies. The presence of sophisticated laboratory facilities and skilled professionals further supports market growth. The region's inclination towards technological adoption has fostered the development and application of organoid-based platforms. Supportive regulatory frameworks encourage investments in organoid research and development.

Europe IPS Cell Derived Organoids market accounted for the second-largest market share due to region's emphasis on healthcare, coupled with a strong scientific community, drives the market. Furthermore, the Germany IPS Cell Derived Organoids provider attributed to hold the largest market share, and the France IPS Cell Derived Organoids providers is projected be the fastest growing market in the Europe region.

The Asia-Pacific IPS Cell Derived Organoids market is expected to be the fastest growing from 2023 to 2032 due to increasing investments in biomedical research, growing healthcare expenditure, and a rising prevalence of chronic diseases can support IPS Cell Derived Organoids development.

Prominent Participants

Key Companies in the IPS Cell Derived Organoids market includes ACROBiosystems (US), Miltenyi Biotec (Germany), ThermoFisher Scientific (US), STEMCELL Technologies (Canada), Bio-Techne (US), Merck KGaA (Germany), Molecular Devices, LLC (US), Corning Incorporated (US), Promega Corporation (US), and Creative Bioarray (US).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TECHNIQUE
• 3.8 DATA MODELING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA MODELING:

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 GROWING ADOPTION OF PERSONALIZED DRUGS
  • 4.2.2 RISING PREVALENCE OF CHRONIC DISEASES
  • 4.2.3 ADVANCEMENTS IN STEM CELL RESEARCH
  • 4.2.4 DRIVER IMPACT ANALYSIS
• 4.3 RESTRAINTS
  • 4.3.1 HIGH COST OF ORGANOID DEVELOPMENT AND MAINTENANCE
  • 4.3.2 REGULATORY HURDLES AND STANDARDIZATION
  • 4.3.3 RESTRAINT IMPACT ANALYSIS
• 4.4 OPPORTUNITY
  • 4.4.1 DEVELOPMENT OF MORE COMPLEX AND FUNCTIONAL ORGANOIDS
  • 4.4.2 EXPANSION OF APPLICATIONS IN DRUG DISCOVERY AND TOXICOLOGY
• 4.5 IMPACT ANALYSIS OF COVID -
  • 4.5.1 IMPACT ON OVERALL HEALTH INDUSTRY
  • 4.5.2 IMPACT ON GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
  • 4.5.3 IMPACT ON SUPPLY CHAIN OF IPS CELL-DERIVED ORGANOIDS
  • 4.5.4 IMPACT ON MARKET DEMAND OF IPS CELL-DERIVED ORGANOIDS
  • 4.5.5 IMPACT ON PRICING OF IPS CELL-DERIVED ORGANOIDS

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 THREAT OF SUBSTITUTES
  • 5.1.5 INTENSITY OF RIVALRY
• 5.2 SUPPLY CHAIN ANALYSIS
  • 5.2.1 RAW MATERIAL
  • 5.2.2 PRODUCTION PROCESS
  • 5.2.3 DISTRIBUTION
  • 5.2.4 END USER

6 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 BRAIN
• 6.3 HEART
• 6.4 LUNG
• 6.5 LIVER
• 6.6 KIDNEY
• 6.7 OTHERS

7 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 DRUG DISCOVERY AND DEVELOPMENT
• 7.3 DISEASE MODELLING
• 7.4 REGENERATIVE MEDICINE

8 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
• 8.3 ACADEMIC AND RESEARCH INSTITUTES
• 8.4 CONTRACT RESEARCH ORGANIZATION

9 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION

• 9.1 OVERVIEW
  • 9.1.1 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2020-2032
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020-2032
• 9.3 EUROPE
  • 9.3.1 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020-2032
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020-2032
• 9.5 REST OF THE WORLD
  • 9.5.1 REST OF THE WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020-2032

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MAJOR GROWTH STRATEGY IN THE GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• 10.3 COMPETITOR DASHBOARD

11 COMPANY PROFILES

• 11.1 ACROBIOSYSTEMS
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 MILTENYI BIOTEC
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 THERMOFISHER SCIENTIFIC
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 STEMCELL TECHNOLOGIES
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 BIO-TECHNE
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 KEY STRATEGIES
• 11.6 MERCK KGAA
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 MOLECULAR DEVICES, LLC
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 CORNING INCORPORATED
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 PROMEGA CORPORATION
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 CREATIVE BIOARRAY
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

LIST OF TABLES

• TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 3 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 4 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 5 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 6 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 7 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 8 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 9 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 10 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 11 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 12 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 13 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 14 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 15 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 16 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 17 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 18 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 19 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 20 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 21 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 22 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 23 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 24 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 25 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 26 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 27 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 28 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 29 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 30 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 31 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 32 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 33 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 34 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 35 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 36 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 37 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 38 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 39 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 40 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 41 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 42 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 43 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 44 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 45 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 46 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 47 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 48 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 49 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 50 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 51 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 52 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 53 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 54 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 55 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 56 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 57 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 58 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 59 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 60 REST OF THE WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 61 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 62 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 63 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 64 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 65 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 66 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 67 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 68 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 69 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 70 ACROBIOSYSTEMS: PRODUCTS OFFERED
• TABLE 71 ACROBIOSYSTEMS: KEY DEVELOPMENTS
• TABLE 72 MILTENYI BIOTEC: PRODUCTS OFFERED
• TABLE 73 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
• TABLE 74 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
• TABLE 75 BIO-TECHNE CORP: PRODUCTS OFFERED
• TABLE 76 MERCK KGAA: PRODUCTS OFFERED
• TABLE 77 MOLECULAR DEVICES.: PRODUCTS OFFERED
• TABLE 78 CORNING INCORPORATED: PRODUCTS OFFERED
• TABLE 79 PROMEGA CORPORATION.: PRODUCTS OFFERED
• TABLE 80 CREATIVE BIOARRAY: PRODUCTS OFFERED

LIST OF FIGURES

• FIGURE 1 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET: STRUCTURE
• FIGURE 2 MARKET DYNAMICS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 3 DRIVER IMPACT ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 4 RESTRAINT IMPACT ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 6 SUPPLY CHAIN ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 7 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2023 (% SHARE)
• FIGURE 8 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• FIGURE 9 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2023 (% SHARE)
• FIGURE 10 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY PRICING, 2019-2032 (USD MILLION)
• FIGURE 11 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2023 (% SHARE)
• FIGURE 12 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY AGE CATEGORY, 2019-2032 (USD MILLION)
• FIGURE 13 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2023 (% SHARE)
• FIGURE 14 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2019-2032 (USD MILLION)
• FIGURE 15 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 16 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 17 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 18 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 19 COMPETITOR DASHBOARD: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 20 ACROBIOSYSTEMS: SWOT ANALYSIS
• FIGURE 21 MILTENYI BIOTEC: SWOT ANALYSIS
• FIGURE 22 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 23 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
• FIGURE 24 STEMCELL TECHNOLOGIES: SWOT ANALYSIS
• FIGURE 25 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 26 MERCK KGAA: SWOT ANALYSIS
• FIGURE 27 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT